Genomics

Dataset Information

RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer


ABSTRACT: RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer

PROVIDER: PRJNA578685 | ENA |

REPOSITORIES: ENA